Oncolytic virus (OV) therapy is a promising cancer treatment strategy, which selectively
replicates in and destroys tumor cells rather than normal cells, thereby effectively releasing …

The field of oncolytic virus (OV) therapy is an innovative and evolving science, taking
advantage of the ability of select viruses to preferentially infect and kill human tumor cells …

Oncolytic viruses (OVs) are potential antitumor agents with unique therapeutic mechanisms.
They possess the ability of direct oncolysis and the induction of antitumor immunity. OV can …

The oncolytic virus (OV) field has entered an exciting period in its evolution in which our
basic understanding of viral biology and anti-cancer potential are being actively translated …

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer
treatment, offering a unique potential to selectively target malignant cells while sparing …

Oncolytic viruses (OVs), above and beyond infecting and lysing malignant cells, interact with
the immune system in complex ways that have important therapeutic significance. While …

Oncolytic viruses (OVs), viruses that specifically result in killing tumor cells, represent a
promising class of cancer therapy. Recently, the focus in the OV therapy field has shifted …

Oncolytic viruses (OVs) are natural or genetically recombinant viruses that selectively infect
and kill tumor cells without affecting normal cell growth. As a novel type of immunotherapy …

Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …

Oncolytic viruses (OVs) have been gaining attention in the pharmaceutical industry as a
novel immunotherapeutic and therapeutic adjuvant due to their ability to induce and boost …